Dr Miller shares our passion for advancing anti-aging science.
Newport Beach, California (PRWEB) November 14, 2013
Vestiage, the science-based anti-aging company, announced today that noted Harvard trained surgeon and non-invasive facial rejuvenation specialist Leonard Miller, MD, FACS FRCS has agreed to join the Vestiage Advisory Committee. Dr. Miller is the Founder of the Boston Center for Rejuvenation and is an active investor in companies that are dedicated to advancing science and technology in anti-aging and aesthetic medicine.
Scott Kimball, CEO of Vestiage said, "Dr. Miller is a dynamic person that is out in front of the developments that impact anti-aging, facial care, and aesthetic medicine. He is one of the more forward thinking and active individuals I've met since we formed Vestiage. His insight into developing technology in the medical field has already led us to add things to our R&D slate for the upcoming years. We are grateful that he has agreed to be a member of our Advisory Committee."
Vestiage was created by Cypress Consumer Partners, a private equity firm focused on health, wellness, fitness, and nutrition in concert with natural products industry production partners and cutting edge ingredient manufacturers. The Vestiage Advisory Committee and executive team is made up of individuals that are experienced and skilled in several disciplines that are important to the company. These include former professional and Olympic athletes, current experts and executives in consumer products sales and marketing, advertising, finance, mergers and acquisitions, corporate strategy, operations, brand development, natural products, medicine and life sciences and other investors.
Vestiage (stock symbol "VEST") is a publicly traded anti-aging company offering premium branded, science-based cosmeceuticals and nutraceuticals. Vestiage is focused on the mission of extending the quality of an active life using human stem cell, marine/ocean, and cutting edge botanically based science and patented botanical ingredients to produce pure, highly potent and effective products. Vestiage creates and distributes cosmeceuticals such as Reluma (http://www.RelumaSkinCare.com) and multifunctional nutraceuticals through Monterey Bay Nutraceuticals (http://www.MontereyBayNutra.com) and RegiMEN™. Vestiage's branded products address the top “in demand” anti-aging consumer concerns. Vestiage research is focused on extending the quality of an active life and human performance science that covers both the cognitive and physical realms. To learn more, please visit the Company website, http://www.VestiageInc.com.
This Press Release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 with respect to our financial condition, results of operations and business. These forwardlooking statements can be identified by the use of terms such as "believe," "expects," "plan," "intend," "may," "will," "should," "can," or "anticipates," or the negative thereof, or variations thereon, or comparable terminology, or by discussions of strategy. These statements involve known and unknown risks, uncertainties and other factors that may cause industry trends or our actual results to be materially different from any future results expressed or implied by these statements. Important factors that may cause our results to differ from these forward-looking statements include, but are not limited to: (i) changes in or new government regulations or increased enforcement of the same, (ii) unavailability of desirable acquisitions or inability to complete them, (iii) increased costs, including from increased raw material or energy prices, (iv) changes in general worldwide economic or political conditions, (v) adverse publicity or negative consumer perception regarding nutritional supplements, anti-aging or stem cell facial care products or stem cell technology in general, (vi) issues with obtaining raw materials of adequate quality or quantity, (vii) litigation and claims, including product liability, intellectual property and other types, (viii) disruptions from or following acquisitions including the loss of customers, (ix) increased competition, (x) slow or negative growth in the anti-aging or cosmetics, beauty, or nutritional supplement industry or the healthy foods or anti-aging channel, (xi) the loss of key personnel or the inability to manage our operations efficiently, (xii) problems with information management systems, manufacturing efficiency and operations, (xiii) insurance coverage issues, (xiv) the volatility of the stock market generally and of our stock specifically, (xv) increases in the cost of borrowings or unavailability of additional debt or equity capital, or both, or fluctuations in foreign currencies, and (xvi) interruption of business or negative impact on sales and earnings due to acts of God, acts of war, terrorism, bio-terrorism, civil unrest and other factors outside of our control.